GlassScriptPhysician profile
Danny Walker
NPI 1114424736
$934.73
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.55 · 2021: $190 · 2022: $438 · 2023: $132 · 2024: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $382.94 | 2021-2024 | Vraylar |
| Novo Nordisk INC | $172.60 | 2021-2023 | Wegovy |
| Boston Scientific Corporation | $128.22 | 2024 | Watchman Access System |
| Lilly USA, LLC | $49.50 | 2021-2022 | |
| Amgen INC. | $47.22 | 2021-2023 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $29.00 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $26.89 | 2022 | |
| Merck Sharp & Dohme LLC | $22.55 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $17.49 | 2022 | |
| Pfizer INC. | $16.08 | 2022 | |
| Halozyme INC | $14.92 | 2023 | |
| Janssen Pharmaceuticals, INC | $14.30 | 2023 | Xarelto |
| Phadia US INC. | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.